Elevated serum IL‐6 levels are also observed in patients with inflammatory bowel disease19, and IL‐6 levels generally correlate with tumor size, stage, and metastasis in colorectal cancer (CRC) patients20. Here, IL6 is linked to colorectal carcinoma.